• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

透析人群慢性肾脏病矿物质和骨异常的表型。

Phenotypes of Mineral Bone Disorder in Chronic Kidney Disease in a Dialysis Population.

机构信息

Unidad de Investigación Médica en Enfermedades Renales, Centro Médico Nacional de Occidente, Instituto Mexicano del Seguro Social, Guadalajara, Jalisco, México.

Unidad de Investigación Médica en Enfermedades Renales, Centro Médico Nacional de Occidente, Instituto Mexicano del Seguro Social, Guadalajara, Jalisco, México.

出版信息

Arch Med Res. 2024 Jun;55(4):103008. doi: 10.1016/j.arcmed.2024.103008. Epub 2024 Jun 1.

DOI:10.1016/j.arcmed.2024.103008
PMID:38824883
Abstract

BACKGROUND

Chronic Kidney Disease-Mineral and Bone Disorder (CKD-MBD) is associated with clinical outcomes. It is necessary to identify the phenotype to make clinical decisions that optimize resources and follow-up.

OBJECTIVE

To determine the frequency of the CKD-MBD phenotype in dialysis patients and the associated factors.

METHODS

Cross-sectional study in 440 patients, evaluated for CKD-MBD. Phenotypes show frequency of high, low or on target levels of PTH, vitamin D and phosphorus. The most common phenotype was used for comparisons.

RESULTS

Age was 37.5 ± 15.8 years, 53% male, 28% were diabetic, 60% on peritoneal dialysis (PD), dialysis vintage was 12.0 months (IQR 3.0-34.3). High PTH was 58%, low vitamin D 82%, high phosphorus 39%, low calcium 50%, and vascular calcification 55%. The combination of high PTH and low vitamin D and high on-target phosphorus was 39%. Those with high PTH and low vitamin D were more likely to use PD (71 vs 51%; p <0.0001), had higher lipids: total cholesterol (159 vs. 152; p = 0.002) and triglycerides (137 vs. 123; p = 0.02), higher potassium (4.7 ± 0.7 vs. 4.9 ± 0.9 mg/dL; p = 0.04), and higher serum creatinine (11.9 ± 4.4 vs. 10.6 ± 3.7 mg/dL; p = 0.01). Predictors of the most common phenotypes were PD use, total cholesterol, and serum creatinine.

CONCLUSIONS

More than one third (38%) of our sample of patients had high PTH and low vitamin D with either high or normal phosphorus. Patients with these phenotypes more frequently used PD, had higher lipids and low potassium. PD use, total cholesterol and serum creatinine were significantly associated with these phenotypes.

摘要

背景

慢性肾脏病-矿物质和骨异常(CKD-MBD)与临床结局相关。有必要确定表型,以便做出优化资源和随访的临床决策。

目的

确定透析患者 CKD-MBD 表型的频率及相关因素。

方法

对 440 例接受 CKD-MBD 评估的患者进行横断面研究。表型显示 PTH、维生素 D 和磷的高水平、低水平或目标水平的频率。使用最常见的表型进行比较。

结果

年龄为 37.5±15.8 岁,53%为男性,28%为糖尿病患者,60%接受腹膜透析(PD),透析时间为 12.0 个月(IQR 3.0-34.3)。高 PTH 为 58%,低维生素 D 为 82%,高磷为 39%,低钙为 50%,血管钙化为 55%。高 PTH 伴低维生素 D 和高目标磷的组合占 39%。高 PTH 伴低维生素 D 的患者更可能使用 PD(71%比 51%;p<0.0001),血脂更高:总胆固醇(159 比 152;p=0.002)和甘油三酯(137 比 123;p=0.02),钾更高(4.7±0.7 比 4.9±0.9 mg/dL;p=0.04),血清肌酐更高(11.9±4.4 比 10.6±3.7 mg/dL;p=0.01)。最常见表型的预测因素是 PD 使用、总胆固醇和血清肌酐。

结论

我们样本中超过三分之一(38%)的患者存在高 PTH 和低维生素 D,伴或不伴高磷。这些表型的患者更频繁地使用 PD,血脂更高,钾更低。PD 使用、总胆固醇和血清肌酐与这些表型显著相关。

相似文献

1
Phenotypes of Mineral Bone Disorder in Chronic Kidney Disease in a Dialysis Population.透析人群慢性肾脏病矿物质和骨异常的表型。
Arch Med Res. 2024 Jun;55(4):103008. doi: 10.1016/j.arcmed.2024.103008. Epub 2024 Jun 1.
2
International variations in serum PTH and calcium levels and their mortality associations in peritoneal dialysis patients: Results from PDOPPS.腹膜透析患者血清 PTH 和钙水平的国际差异及其与死亡率的关系:PDOPPS 研究结果。
Perit Dial Int. 2024 Jul;44(4):275-286. doi: 10.1177/08968608241235516. Epub 2024 Mar 19.
3
Serum markers of low-turnover bone disease in Mexican children with chronic kidney disease undergoing dialysis.接受透析的墨西哥慢性肾病儿童低转换型骨病的血清标志物
Perit Dial Int. 2006 Jan-Feb;26(1):78-84.
4
[Management of bone and mineral metabolism disorders before the dialysis stage remains still perfectible. Data from the French Phosphorus and Calcium Survey Photo-Graphe].透析阶段前骨与矿物质代谢紊乱的管理仍有完善空间。来自法国磷与钙调查(Photo-Graphe)的数据
Nephrol Ther. 2017 Nov;13(6):470-478. doi: 10.1016/j.nephro.2017.02.009. Epub 2017 Aug 23.
5
Mineral and bone disorder in hemodialysis patients in the Tibetan Plateau: a multicenter cross-sectional study.藏高原血液透析患者的矿物质和骨代谢紊乱:一项多中心横断面研究。
Ren Fail. 2019 Nov;41(1):636-643. doi: 10.1080/0886022X.2019.1635892.
6
The relationship between urinary kidney injury molecule-1 and blood bone metabolism markers in patients with chronic kidney disease
.慢性肾脏病患者尿肾损伤分子-1与血骨代谢标志物之间的关系
Clin Nephrol. 2020 Feb;93(2):65-76. doi: 10.5414/CN109763.
7
Chronic kidney disease mineral bone disorder and health-related quality of life among incident end-stage renal-disease patients.初发终末期肾病患者的慢性肾脏病矿物质和骨异常与健康相关生活质量
J Ren Nutr. 2007 Sep;17(5):305-13. doi: 10.1053/j.jrn.2007.06.005.
8
Association of Vitamin D Metabolites with Parathyroid Hormone, Fibroblast Growth Factor-23, Calcium, and Phosphorus in Dogs with Various Stages of Chronic Kidney Disease.不同阶段慢性肾脏病犬维生素D代谢产物与甲状旁腺激素、成纤维细胞生长因子-23、钙和磷的相关性
J Vet Intern Med. 2017 May;31(3):791-798. doi: 10.1111/jvim.14653. Epub 2017 Feb 10.
9
Etelcalcetide Utilization, Dosing Titration, and Chronic Kidney Disease-Mineral and Bone Disease (CKD-MBD) Marker Responses in US Hemodialysis Patients.依特卡塞特在美接受血液透析患者中的应用、剂量滴定和慢性肾脏病-矿物质和骨异常(CKD-MBD)标志物反应。
Am J Kidney Dis. 2022 Mar;79(3):362-373. doi: 10.1053/j.ajkd.2021.05.020. Epub 2021 Jul 15.
10
Adherence to Kidney Disease: Improving Global Outcomes Mineral and Bone Guidelines for Monitoring Biochemical Parameters.遵守肾脏病:改善全球肾脏病预后组织矿物质和骨代谢异常诊治指南监测生化参数。
Am J Nephrol. 2019;49(3):225-232. doi: 10.1159/000497477. Epub 2019 Feb 28.

引用本文的文献

1
Proposal for delta check limits of frequently requested hormones using real-world data.利用真实世界数据制定常用激素的delta检查限值的建议。
Biochem Med (Zagreb). 2025 Feb 15;35(1):010704. doi: 10.11613/BM.2025.010704.